Treatment modalities of necrobiosis lipoidica: a concise systematic review


Submitted: 5 December 2014
Accepted: 26 April 2015
Published: 8 June 2015
Abstract Views: 2588
PDF: 1729
Suppl. Table: 376
HTML: 488
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Amir Feily Department of Dermatology, Jahrom University of Medical Sciences, Iran, Islamic Republic of.
  • Shadi Mehraban Department of Dermatology, Jahrom University of Medical Sciences, Iran, Islamic Republic of.
Necrobiosis lipoidica (NL) is a rare inflammatory granulomatous skin disorder closely associated with diabetes mellitus. The aim of this paper is to review and discuss all the treatment modalities proposed and tested for this disease. A systematic review of the existing literature was conducted to investigate all the available data and summarize all the clinical trials, case reports and original articles on NL. Two major databases (PubMed and Google Scholar) were used. We have examined about 70 articles. Numerous treatment modalities have been currently investigated to compare recalcitrant NL. Being rare, most of the studies regarding this disease are case reports or small-scale clinical trials. We have found that, in spite of plentiful investigations carried out during the years, there is no treatment modality that has proved to be utterly satisfactory in treating NL.

Supporting Agencies


Feily, A., & Mehraban, S. (2015). Treatment modalities of necrobiosis lipoidica: a concise systematic review. Dermatology Reports, 7(2). https://doi.org/10.4081/dr.2015.5749

Downloads

Download data is not yet available.

Citations